U.K. Pharmaceuticals & Biotech Upcoming Dividends

Hikma Pharmaceuticals

Market Cap: UK£3.5b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

AstraZeneca

Market Cap: UK£181.5b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£74.9b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£31.7b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.